ABSTRACT:
Diabetes is a disorder which is characterized by increase in blood glucose level beyond normal value. Now days it is a metabolic disorder and considered as one of the major cause for the death of patients worldwide. Hence there is always a need for the development of newer scaffolds which are useful in treatment of diabetes. In the research computational chemistry plays an important role to discover new possible medicines. In this work, docking analysis has been carried out to study the effects of substituted pyrimidin-2-one on Dipeptidyl peptidase-4 (DPP4). Docking study shows that compound A5 having 2,4-difluorophenyl and 2-hydroxy phenyl group has a potent (IC50 28.13 µM), selective and in vitro efficacious DPP-4 inhibitor. Further molecular modeling revealed compound A5 can fit in the enzyme pocket topologically very well with the pyrimidin-2-one moiety providing hydrogen bond interaction with Glu 205 and Ser 209 of DPP-4. Based on these results, compound A5 might be a promising lead compound for further optimization in the treatment of T2DM.
Cite this article:
Prerana A. Chavan, Shailaja B. Jadhav. Docking Studies, Synthesis and Evaluation of Novel Pyrimidin-2-one Derivatives As a Dipeptidyl Peptidase IV Inhibitors. Research Journal of Pharmacy and Technology. 2021; 14(11):5973-7. doi: 10.52711/0974-360X.2021.01037
Cite(Electronic):
Prerana A. Chavan, Shailaja B. Jadhav. Docking Studies, Synthesis and Evaluation of Novel Pyrimidin-2-one Derivatives As a Dipeptidyl Peptidase IV Inhibitors. Research Journal of Pharmacy and Technology. 2021; 14(11):5973-7. doi: 10.52711/0974-360X.2021.01037 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-11-63
REFERENCES:
1. Hazaratali Panari, Vegunarani.M. Study on Complications of Diabetes Mellitus among the Diabetic Patients. Asian J. Nur. Edu. and Research. 2016; 6(2): 171-182.
2. Mohd. Yaqub Khan, Poonam Gupta, Bipin Bihari, Vikas Kumar Verma. A Review on Diabetes and Its Management. Asian J. Pharm. Res. 2013; 3(1): 27-32.
3. Samidha Kamtekar, Vrushali Keer. Management of Diabetes: A Review. Research J. Pharm. and Tech. 2014; 7(9): 1065-1072.
4. AR Umarkar, AK Raut, SS Sonone, SS Pawar, RS Deshmukh, NV Bharude. Dibetes in India: A Review. Research J. Pharmacology and Pharmacodynamics. 2011; 3(6): 345-352.
5. SM Bhanushali, KM Modh, IS Anand, CN Patel, JB Dave. Novel Approaches for Diabetes Mellitus: A Review. Research J. Pharmacology and Pharmacodynamics. 2010; 2(2): 141-147.
6. Karthik Dhananjayan, Arunachalam Sumathy, Sivanandy Palanisamy. Dipeptidylpeptidase-4 Inhibitory Activity of Pergularia Daemia (Forsk) – An In-vitro Estimation. Asian J. Research Chem. 2013; 6(6): 523-524.
7. Indrayani D. Raut, Akshada N. Kakade, Jadhav Snehal, Jadhav Priyanka, Kabir Amruta. Survey on Antidiabetic Drugs. Res. J. Pharmacology and Pharmacodynamics. 2017; 9(1): 10-12.
8. Sheela Victor, Sarah Johnson, Parimala.S., Arpana. Joy. C, P S Sundar Rao. Leadership Roles of Nurses in Assessing and Managing Psychosocial Problems of Type 2 Diabetes in India. Int. J. Adv. Nur. Management. 2017; 5(1): 77-81.
9. Sharma Priya, Malik Sujeeta. Knowledge on Management of Diabetes Mellitus among Patients with type II Diabetes Mellitus in a Selected Community Health Centre of Dadra and Nagar Haveli Area. Asian J. Nursing Education and Research. 2019; 9(1):109-112.
10. Thressia. P.A. (Sr. Tresa Anto) , Rajeev. Kumar. N.. Effect of Sleep Duration on Obesity and the Glycemic level in Patients with Type 2 Diabetes. Asian J. Nur. Edu. and Research, 2014; 4(4): 502-507.
11. F. Bigi, et al, Montmorillonite KSF as an Inorganic, Water Stable, and Reusable Catalyst for the Knoevenagel Synthesis of Coumarin-3-carboxylic Acids, J. Org. Chem., 1999; 64: 1033-1035.
12. B.B. Dey, Y. Sankaranarayan, J. Ind. Chem. Soc., 1934; 11: 687-689.
13. A.P. Dwivedi, et al, Synthesis and antihyperglycemic activity of novel N-acyl-2-arylethylamines and N-acyl-3-coumarylamines, Bioorg. Med. Chem. Lett., 2008; 18: 2301-2305.
14. L. Hansen,et al, Endocrinology, 1999; 140: 5356-5363.
15. D. Kim, et al, (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes, J. Med. Chem., 2005; 48: 141-151.
16. M. Nabeno, et al, A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site, Biochem. Biophys. Res. Commun., 2013; 434: 191-196.
17. O. Nicolotti, I. et al, J. Chem. Inf. Modell., 2009; 49: 2290-2302.
18. C.M. Ripsin, H. Kang, R.J. Urban, Management of Blood Glucose in Type 2 Diabetes Mellitus, Am. Fam. Phys., 2009; 79(1): 29-36.
19. Godavari A, Amutha K. In vitro Antidiabetic Activity of Garcinia mangostana by Enzymatic Inhibition Assay. Research J. Pharm. and Tech. 2017; 10(2): 508-512
20. S. Sandhu, Y. Bansal, O. Silakari, G. Bansal, Coumarin hybrids as novel therapeutic agents, Bioorg. Med. Chem., 2014; 22: 3806-3814.
21. C.M. Sena, C.F. Bento, P. Pereira, R. Seiça, Diabetes mellitus: New challenges and innovative therapies EPMA J., 2010; 1: 138-163.
22. M. Totrov, R. Abagyan, Flexible ligand docking to multiple receptor conformations: a practical alternative, Curr. Opin. Struct. Biol., 2008; 18: 178-184.
23. Schrodinger, LLC, 2015. The PyMOL Molecular Graphics System, Version 1.8.
24. QikProp, Schrödinger, LLC, 2009. New York, NY.
25. Ratnamala P Sonawane, Green synthesis of pyrimidine derivative, International Letters of Chemistry, Physics and chemistry, 2014; 14 (1): 64-68.
26. D.N. Shah, N.M. Shah, J. Org. Chem., 1954; 19: 1681-1685.
27. R. Sharma, S.S. Soman, Design and synthesis of novel diamide derivatives of glycine as antihyperglycemic agentsSynth. Commun., 2016; 46: 1307-1317.
28. C.M. Sousa, J. Berthet, S. Delbaere, P.J. Coelho, Photochromic Fused-Naphthopyrans without Residual Color, J. Org. Chem., 2012; 77: 3959-3968.
29. Ganesh Samala et al, Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors, Bioorganic and Medicinal Chemistry, 2014; 22(15): 4223-4232.